Canada Blood Gas and Electrolyte Analyzer Market Insight
Canada blood gas and electrolyte analyzer market size is growing at a 2.18% CAGR, driven by the rising prevalence of chronic and critical diseases, and growing adoption of point-of-care testing. The market is supported by advancements in diagnostic technologies and increasing need for real-time patient monitoring in hospitals and emergency care settings.
Canada Blood Gas and Electrolyte Analyzer Market Insights Forecasts to 2035
- The Canada Blood Gas and Electrolyte Analyzer Market Size Was Estimated at USD 82.9 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 2.18% from 2025 to 2035
- The Canada Blood Gas and Electrolyte Analyzer Market Size is Expected to Reach USD 102.9 Million by 2035
Notable Insights for Canada Blood Gas and Electrolyte Analyzer Market
- By product type, instruments dominate the Canada blood gas and electrolyte analyzer market, accounting for the largest revenue share in 2024, generating approximately USD 45 million, driven by growing adoption in hospitals, clinics, and diagnostic laboratories.
- By modality, the portable segment is the fastest growing in the Canada blood gas and electrolyte analyzer market, holding an estimated 35-37% market share in 2024, driven by rising point-of-care testing demand and home healthcare adoption.
- Abbott Laboratories has generated total revenue of approximately USD 40 billion in 2025, maintaining a strong presence in blood gas and electrolyte analyzer systems
- Healthcare demand is strengthening the market, as increasing hospital admissions and critical care cases are driving the need for rapid blood gas and electrolyte testing, particularly in intensive care units and emergency departments
Download the eBook (ToC)
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the Canada blood gas and electrolyte analyzer market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in Canada Blood Gas and Electrolyte Analyzer Market
-
- Abbott Laboratories
- F. Hoffmann-La Roche
- Siemens Healthineers
- Danaher Corporation
- Nova Biomedical
- Werfen
- Others
Recent Developments:
- In March 2026, Canada’s blood gas and electrolyte analyzer market advanced with Roche Diagnostics’ cobas b series, contributing to CAD 95 million revenue, driven by ICU adoption, point-of-care expansion, and rising critical care demand.
- In April 2024, Canada’s blood gas and electrolyte analyzer market expanded as the portable analyzer segment gained traction, generating approximately USD 42 million, driven by ICU, neonatal, and emergency care adoption and point-of-care testing growth.
Market Segmentation:
Canada Blood Gas and Electrolyte Analyzer Market, By Product Type
-
- Consumables
- Instruments
Canada Blood Gas and Electrolyte Analyzer Market, By Modality
-
- Portable
- Benchtop
- Laboratory
Canada Blood Gas and Electrolyte Analyzer Market, By End User
-
- Hospitals
- Diagnostic Laboratories
- Point-of-Care Settings
- Others
Expert Views:
The Canadian market for blood gas and electrolyte analyzers is predicted to have steady growth due to increased demand for faster testing and critical patient monitoring. It is predicted that consumables will account for a greater proportion due to their repeated use, and that there will be more growth in portable devices in the coming years.